Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma of Lung × Fulvestrant × Clear all

Sponsor

Conditions

Breast Neoplasms 93 Neoplasms 12 Neoplasm Metastasis 12 Hereditary Sensory and Autonomic Neuropathies 3 Advanced Breast Cancer 3 Recurrence 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Solid Malignancies 1 Recurrent Uterine Corpus Carcinoma 1 Neoplasms by Site 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Cancer 1 HER2-positive Breast Cancer 1 Exanthema 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Breast Cancer Metastatic 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Carboplatin 22 Bevacizumab 17 Paclitaxel 16 Pemetrexed 14 Radiotherapy 11 Erlotinib Hydrochloride 11 Docetaxel 7 Gemcitabine 5 Cetuximab 5 ceritinib 4 Taxes 4 Cisplatin 4 pembrolizumab 3 Surgical Procedures, Operative 3 Radiosurgery 3 Metformin 3 Gefitinib 3 Cyclophosphamide 3 pegfilgrastim 2 capmatinib 2 Thalidomide 2 Sorafenib 2 Radiotherapy, Conformal 2 Nivolumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Albumin-Bound Paclitaxel 2 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 2 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡